Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margitta Retz

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
BMC Urology|March 5, 2008
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsHenrik Suttmann, Margitta Retz, Friedrich Paulsen, et al.
BJU International|August 15, 2012
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancerMatthias M Heck, Mark Thalgott, Margitta Retz, et al.
Cancer|September 21, 2004
The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinomaJan Lehmann, Margitta Retz, Nils Nürnberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using <sup>68</sup>Ga-PSMA PET/CTMarie Bieth, Markus Krönke, Robert Tauber, et al.
Anticancer Research|May 18, 2012
Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombusThomas Horn, Mark K Thalgott, Tobias Maurer, et al.
Anticancer Research|September 27, 2015
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical ProstatectomyMark Thalgott, Brigitte Rack, Thomas Horn, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 25, 2016
Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 yearsThomas Mücke, Herbert Deppe, Jana Hein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate CancerAndrei Gafita, Isabel Rauscher, Margitta Retz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
Early Prostate-Specific Antigen Changes and Clinical Outcome After <sup>177</sup>Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Matthias M Heck, Isabel Rauscher, et al.
World Journal of Urology|August 12, 2015
Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survivalSebastian Christoph Schmid, Tina Zahel, Bernhard Haller, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
BMC Urology|March 5, 2008
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsHenrik Suttmann, Margitta Retz, Friedrich Paulsen, et al.
BJU International|August 15, 2012
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancerMatthias M Heck, Mark Thalgott, Margitta Retz, et al.
Cancer|September 21, 2004
The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinomaJan Lehmann, Margitta Retz, Nils Nürnberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using <sup>68</sup>Ga-PSMA PET/CTMarie Bieth, Markus Krönke, Robert Tauber, et al.
Anticancer Research|May 18, 2012
Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombusThomas Horn, Mark K Thalgott, Tobias Maurer, et al.
Anticancer Research|September 27, 2015
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical ProstatectomyMark Thalgott, Brigitte Rack, Thomas Horn, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 25, 2016
Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 yearsThomas Mücke, Herbert Deppe, Jana Hein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate CancerAndrei Gafita, Isabel Rauscher, Margitta Retz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
Early Prostate-Specific Antigen Changes and Clinical Outcome After <sup>177</sup>Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Matthias M Heck, Isabel Rauscher, et al.
World Journal of Urology|August 12, 2015
Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survivalSebastian Christoph Schmid, Tina Zahel, Bernhard Haller, et al.
Pageof 10